Mechanisms underlying in vivo polysaccharide-specific immunoglobulin responses to intact extracellular bacteria

Annals of the New York Academy of Sciences

Volumn 1253, Issue 1, 2012, Pages 92-101

  Snapper, Clifford M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Antibody; Bacteria; Immunity; Polysaccharide; T cell; Vaccine

Indexed keywords

BRUTON TYROSINE KINASE; CD1 ANTIGEN; CD40 LIGAND; IMMUNOGLOBULIN D ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE; TOLL LIKE RECEPTOR 2;

ANTIBODY TITER; BACTERIAL CLEARANCE; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOGENICITY; NEISSERIA MENINGITIDIS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS);

EID: 84860245296     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06329.x     Document Type: Review

References (89)

1. AlonsoDeVelasco, E., A.F. Verheul, J. Verhoef & H. Snippe. 1995. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol. Rev. 59: 591-603.
2. Mond, J.J., A. Lees & C.M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13: 655-692.
3. Kalka-Moll, W.M., A.O. Tzianabos, P.W. Bryant, et al. 2002. Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J. Immunol. 169: 6149-6153.
4. Cobb, B.A., Q. Wang, A.O. Tzianabos & D.L. Kasper. 2004. Polysaccharide processing and presentation by the MHCII pathway. Cell 117: 677-687.
5. Harding, C.V., R.W. Roof, P.M. Allen & E.R. Unanue. 1991. Effects of pH and plysaccharides on peptide binding to class II major histocompatiblity complex molecules. Proc. Natl. Acad. Sci. USA 88: 2740-2744.
6. Ishioka, G.Y., A.G. Lamont, D. Thomson, et al. 1992. MHC interaction and T cell recognition of carbohydrates and glycopeptides. J. Immunol. 148: 2446-2451.
7. Baker, P.J. 1992. T cell regulation of the antibody response to bacterial polysaccharide antigens: an examination of some general characteristics and their implications. J. Infect. Dis. 165(Suppl 1): S44-S48.
8. Mongini, P.K., K.E. Stein & W.E. Paul. 1981. T cell regulation of IgG subclass antibody production in response to T-independent antigens. J. Exp. Med. 153: 1-12.
9. Jeurissen, A., M. Wuyts, A. Kasran, et al. 2002. Essential role for CD40 ligand interactions in T lymphocyte-mediated modulation of the murine immune response to pneumococcal capsular polysaccharides. J. Immunol. 168: 2773-2781.
10. Kobrynski, L.J., A.O. Sousa, A.J. Nahmias & F.K. Lee. 2005. Cutting edge: antibody production to pneumococcal polysaccharides requires CD1 molecules and CD8+ T Cells. J. Immunol. 174: 1787-1790.
11. Moens, L., A. Jeurissen, S. Nierkens, et al. 2009. Generation of antibody responses to pneumococcal capsular polysaccharides is independent of CD1 expression in mice. Infect. Immun. 77: 1976-1980.
12. Brunswick, M., F.D. Finkelman, P.F. Highet, et al. 1988. Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation. J. Immunol. 140: 3364-3372.
13. Snapper, C.M. & J.J. Mond. 1996. A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J. Immunol. 157: 2229-2233.
14. Pecanha, L.M., C.M. Snapper, F.D. Finkelman, et al. 1991. Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependence. J. Immunol. 146: 833-839.
15. Snapper, C.M. & J.J. Mond. 1993. Towards a comprehensive view of immunoglobulin class switching. Immunol. Today 14: 15-17.
16. Sen, G., A.Q. Khan, Q. Chen & C.M. Snapper. 2005. In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands. J. Immunol. 175: 3084-3091.
17. Arjunaraja, S., P. Massari, L.M. Wetzler, A. Lees, J. Colino & C.M. Snapper. 2011. The nature of an in vivo anti-capsular polysaccharide response is markedly influenced by the composition and/or architecture of the bacterial subcapsular domain. J. Immunol. In press.
18. Massari, P., P. Henneke, Y. Ho, et al. 2002. Cutting edge: immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J. Immunol. 168: 1533-1537.
19. Latz, E., J. Franko, D.T. Golenbock & J.R. Schreiber. 2004. Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity. J. Immunol. 172: 2431-2438.
20. Khan, A.Q., Q. Chen, Z.Q. Wu, et al. 2005. Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2. Infect. Immun. 73: 298-307.
21. Balazs, M., F. Martin, T. Zhou & J.F. Kearney. 2002. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17: 341-352.
22. Litinskiy, M.B., B. Nardelli, D.M. Hilbert, et al. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3: 822-829.
23. Craxton, A., D. Magaletti, E.J. Ryan & E.A. Clark. 2003. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101: 4464-4471.
24. Schneider, P. 2005. The role of APRIL and BAFF in lymphocyte activation. Curr. Opin. Immunol. 17: 282-289.
25. von Bulow, G.U., J.M. van Deursen & R.J. Bram. 2001. Regulation of the T-independent humoral response by TACI. Immunity 14: 573-582.
26. Mackay, F. & J.L. Browning. 2002. BAFF: a fundamental survival factor for B cells. Nat. Rev. Immunol. 2: 465-475.
27. MacLennan, I.C., K.M. Toellner, A.F. Cunningham, et al. 2003. Extrafollicular antibody responses. Immunol. Rev. 194: 8-18.
28. El Shikh, M.E., R.M. El Sayed, A.K. Szakal & J.G. Tew. 2009. T-independent antibody responses to T-dependent antigens: a novel follicular dendritic cell-dependent activity. J. Immunol. 182: 3482-3491.
29. Huard, B., L. Arlettaz, C. Ambrose, et al. 2004. BAFF production by antigen-presenting cells provides T cell co-stimulation. Int. Immunol. 16: 467-475.
30. Trinchieri, G. & A. Sher. 2007. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7: 179-190.
31. Franchi, L., C. McDonald, T.D. Kanneganti, et al. 2006. Nucleotide-binding oligomerization domain-like receptors: intracellular pattern recognition molecules for pathogen detection and host defense. J. Immunol. 177: 3507-3513.
32. Robinson, M.J., D. Sancho, E.C. Slack, et al. 2006. Myeloid C-type lectins in innate immunity. Nat. Immunol. 7: 1258-1265.
33. Bachmann, M.F. & G.T. Jennings. 2010. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10: 787-796.
34. Kraal, G., H. Ter Hart, C. Meelhuizen, et al. 1989. Marginal zone macrophages and their role in the immune response against T-independent type 2 antigens: modulation of the cells with specific antibody. Eur. J. Immunol. 19: 675-680.
35. Colino, J., G. Chattopadhyay, G. Sen, et al. 2009. Parameters underlying distinct T cell-dependent polysaccharide-specific IgG responses to an intact gram-positive bacterium versus a soluble conjugate vaccine. J. Immunol. 183: 1551-1559.
36. Kovacsovics-Bankowski, M., K. Clark, B. Benacerraf & K.L. Rock. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA. 90: 4942-4946.
37. Ziegler, H.K., C.A. Orlin & C.W. Cluff. 1987. Differential requirements for the processing and presentation of soluble and particulate bacterial antigens by macrophages. Eur. J. Immunol. 17: 1287-1296.
38. Vidard, L., M. Kovacsovics-Bankowski, S.K. Kraeft, et al. 1996. Analysis of MHC class II presentation of particulate antigens of B lymphocytes. J. Immunol. 156: 2809-2818.
39. Pincus, J.H., E. Haber, M. Katz & A.M. Pappenheimer, Jr. 1968. Antibodies to pneumococcal polysaccharides: relation between binding and electrophoretic heterogeneity. Science 162: 667-668.
40. Guttormsen, H.K., L.M. Wetzler, R.W. Finberg & D.L. Kasper. 1998. Immunologic memory induced by a glycoconjugate vaccine in a murine adoptive lymphocyte transfer model. Infect. Immun. 66: 2026-2032.
41. Guttormsen, H.K., A.H. Sharpe, A.K. Chandraker, et al. 1999. Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines. Infect. Immun. 67: 6375-6384.
42. Muthukkumar, S. & K.E. Stein. 2004. Immunization with meningococcal polysaccharide-tetanus toxoid conjugate induces polysaccharide-reactive T cells in mice. Vaccine 22: 1290-1299.
43. Sorensen, U.B., J. Henrichsen, H.C. Chen & S.C. Szu. 1990. Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. Microb. Pathog. 8: 325-334.
44. Jedrzejas, M.J. 2004. Extracellular virulence factors of Streptococcus pneumoniae. Front. Biosci. 9: 891-914.
45. Whitfield, C. 2006. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem. 75: 39-68.
46. Rietschel, E.T., H. Brade, O. Holst, et al. 1996. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol. 216: 39-81.
47. Beuvery, E.C., F. Miedema, R.W. van Delft, et al. 1983. Preparation and physicochemical and immunological characterization of polysaccharide-outer membrane protein complexes of Neisseria meningitidis. Infect. Immun. 40: 369-380.
48. Lucas, A.H., K.D. Moulton, V.R. Tang & D.C. Reason. 2001. Combinatorial library cloning of human antibodies to Streptococcus pneumoniae capsular polysaccharides: variable region primary structures and evidence for somatic mutation of Fab fragments specific for capsular serotypes 6B, 14, and 23F. Infect. Immun. 69: 853-864.
49. Zhou, J., K.R. Lottenbach, S.J. Barenkamp, et al. 2002. Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23F. Infect. Immun. 70: 4083-4091.
50. Haber, E., M.N. Margolies & L.E. Cannon. 1977. Origins of antibody diversity: insight gained from amino acid sequence studies of elicited antibodies. Cold. Spring. Harb. Symp. Quant. Biol. 41: Pt 2 647-659.
51. Paul, W.E., G.W. Siskind, B. Benacerraf & Z. Ovary. 1967. Secondary antibody responses in haptenic systems: cell population selection by antigen. J. Immunol. 99: 760-770.
52. Kanswal, S., N. Katsenelson, W. Allman, et al. 2011. Suppressive effect of bacterial polysaccharides on BAFF system is responsible for their poor immunogenicity. J. Immunol. 186: 2430-2443.
53. Lanoue, A., M. R. Clatworthy, P. Smith, et al. 2004. SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J. Exp. Med. 200: 1383-1393.
54. Koppel, E.A., C.W. Wieland, V.C. van den Berg, et al. 2005. Specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) expressed by marginal zone macrophages is essential for defense against pulmonary Streptococcus pneumoniae infection. Eur. J. Immunol. 35: 2962-2969.
55. Chen, Z., S.B. Koralov & G. Kelsoe. 2000. Regulation of humoral immune responses by CD21/CD35. Immunol. Rev. 176: 194-204.
56. Courtney, A.H., E.B. Puffer, J.K. Pontrello, et al. 2009. Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation. Proc. Natl. Acad. Sci. USA. 106: 2500-2505.
57. Dintzis, H.M., R.Z. Dintzis & B. Vogelstein. 1976. Molecular determinants of immunogenicity: the immunon model of immune response. Proc. Natl. Acad. Sci. USA. 73: 3671-3675.
58. Kamboj, K.K., H.L. Kirchner, R. Kimmel, et al. 2003. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein. J. Infect. Dis. 187: 1629-1638.
59. Grabitzki, J. & G. Lochnit. 2009. Immunomodulation by phosphocholine-biosynthesis, structures and immunological implications of parasitic PC-epitopes. Mol. Immunol. 47: 149-163.
60. Briles, D.E., J.D. King, M.A. Gray, et al. 1996. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 14: 858-867.
61. Khan, A.Q., A. Lees & C.M. Snapper. 2004. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4+ T cell help. J. Immunol. 172: 532-539.
62. Chen, Q., J.L. Cannons, J.C. Paton, et al. 2008. A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine. J. Immunol. 181: 8258-8266.
63. Dong, C., U.A. Temann & R.A. Flavell. 2001. Cutting edge: critical role of inducible costimulator in germinal center reactions. J. Immunol. 166: 3659-3662.
64. Huang, D.C., S. Cory & A. Strasser. 1997. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 14: 405-414.
65. Chattopadhyay, G., A.Q. Khan, G. Sen, et al. 2007. Transgenic expression of Bcl-xL or Bcl-2 by Murine B Cells enhances the In vivo antipolysaccharide, but Not antiprotein, response to intact streptococcus pneumoniae. J. Immunol. 179: 7523-7534.
66. Avery, O.T. & W.F. Goebel. 1931. Chemo-immunological studies on conjugated carbohydrate-proteins: V. The immunological specificity of an antigen prepared by combining the capsular polysaccharide of type III pneumococcus with foreign protein. J. Exp. Med. 54: 437-447.
67. Ahmad, H. & E.K. Chapnick. 1999. Conjugated polysaccharide vaccines. Infect. Dis. Clin. North. Am. 13: 113-133, vii.
68. Beuvery, E.C., F. van Rossum & J. Nagel. 1982. Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates. Infect. Immun. 37: 15-22.
69. Schneerson, R., O. Barrera, A. Sutton & J.B. Robbins. 1980. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J. Exp. Med. 152: 361-376.
70. Sen, G., Q. Chen & C.M. Snapper. 2006. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels. Infect. Immun. 74: 2177-2186.
71. Satterthwaite, A.B., H. Cheroutre, W.N. Khan, et al. 1997. Btk dosage determines sensitivity to B cell antigen receptor cross-linking. Proc. Natl. Acad. Sci. USA. 94: 13152-13157.
72. Satterthwaite, A.B., Z. Li & O.N. Witte. 1998. Btk function in B cell development and response. Semin. Immunol. 10: 309-316.
73. Khan, A.Q., G. Sen, S. Guo, et al. 2006. Induction of in vivo antipolysaccharide immunoglobulin responses to intact Streptococcus pneumoniae is more heavily dependent on Btk-mediated B-cell receptor signaling than antiprotein responses. Infect. Immun. 74: 1419-1424.
74. Song, H. & J. Cerny. 2003. Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen. J. Exp. Med. 198: 1923-1935.
75. Rubtsov, A., P. Strauch, A. Digiacomo, et al. 2005. Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response. Immunity 23: 527-538.
76. Girkontaite, I., K. Missy, V. Sakk, et al. 2001. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat. Immunol. 2: 855-862.
77. Colino, J. & I. Outschoorn. 1998. Dynamics of the murine humoral immune respose to neisseria meningitidis group B capsular polysaccharide. Infect. Immun. 66: 505-513.
78. Kasper, D.L., C.J. Baker, R.S. Baltimore, et al. 1979. Immunodeterminant specificity of human immunity to type III group B streptococcus. J. Exp. Med. 149: 327-339.
79. Guttormsen, H.K., C.J. Baker, M.H. Nahm, et al. 2002. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14. Infect. Immun. 70: 1724-1738.
80. Lee, K.S., G. Sen & C.M. Snapper. 2005. Endogenous CD4+ CD25+ regulatory T cells play no apparent role in the acute humoral response to intact Streptococcus pneumoniae. Infect. Immun. 73: 4427-4431.
81. Sette, A., M. Moutaftsi, J. Moyron-Quiroz, et al. 2008. Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity 28: 847-858.
82. Rigden, D.J., M.Y. Galperin & M.J. Jedrzejas. 2003. Analysis of structure and function of putative surface-exposed proteins encoded in the Streptococcus pneumoniae genome: a bioinformatics-based approach to vaccine and drug design. Crit. Rev. Biochem. Mol. Biol. 38: 143-168.
83. Lopez, R., J.L. Garcia, E. Garcia, et al. 1992. Structural analysis and biological significance of the cell wall lytic enzymes of Streptococcus pneumoniae and its bacteriophage. FEMS Microbiol. Lett. 79: 439-447.
84. Ronda, C., J.L. Garcia, E. Garcia, et al. 1987. Biological role of the pneumococcal amidase. Cloning of the lytA gene in Streptococcus pneumoniae. Eur. J. Biochem. 164: 621-624.
85. Navarre, W.W. & O. Schneewind. 1999. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol. Mol. Biol. Rev. 63: 174-229.
86. Chattopadhyay, G., Q. Chen, J. Colino, et al. 2009. Intact bacteria inhibit the induction of humoral immune responses to bacterial-derived and heterologous soluble T cell-dependent antigens. J. Immunol. 182: 2011-2019.
87. Harnett, M.M., A.J. Melendez & W. Harnett. 2009. The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease. Clin. Exp. Immunol. 159: 256-267.
88. Casey, R., J. Newcombe, J. McFadden & K.B. Bodman-Smith. 2008. The acute-phase reactant C-reactive protein binds to phosphorylcholine-expressing Neisseria meningitidis and increases uptake by human phagocytes. Infect. Immun. 76: 1298-1304.
89. Lysenko, E.S., J. Gould, R. Bals, et al. 2000. Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Infect. Immun. 68: 1664-1671.